# 8-K filed: enGene Therapeutics Inc.

> sec 8k · VERIFIED · 2026-06-15

<b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001193125-26-270384 <b>Size:</b> 451 KB
<br>Item 2.02: Results of Operations and Financial Condition
<br>Item 2.05: Cost Associated with Exit or Disposal Activities
<br>Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
<br>Item 7.01: Regulation FD Disclosure
<br>Item 8.01: Other Events
<br>Item 9.01: Financial Statements and Exhibits

- Company: enGene Therapeutics Inc.
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1980845/000119312526270384/0001193125-26-270384-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.